Owc Pharmaceutical Research Stock Filter Stocks by Fundamentals
| OWCP Stock | USD 0.0001 0.00 0.00% |
OWC Pharmaceutical Research fundamentals help investors to digest information that contributes to OWC Pharmaceutical's financial success or failures. It also enables traders to predict the movement of OWC Pink Sheet. The fundamental analysis module provides a way to measure OWC Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OWC Pharmaceutical pink sheet.
OWC |
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
OWC Fundamentals
| Return On Asset | -0.64 | |||
| Current Valuation | 49.75 K | |||
| Shares Outstanding | 497.5 M | |||
| Shares Owned By Insiders | 11.15 % | |||
| Price To Earning | (12.76) X | |||
| Price To Book | 42.29 X | |||
| EBITDA | (10.25 M) | |||
| Net Income | (10.26 M) | |||
| Cash And Equivalents | 1.47 M | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 3.12 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (2.5 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -224.47 | |||
| Market Capitalization | 49.75 K | |||
| Total Asset | 3.55 M | |||
| Retained Earnings | (25.14 M) | |||
| Working Capital | (75 K) | |||
| Current Asset | 112 K | |||
| Current Liabilities | 187 K | |||
| Z Score | -16.4 | |||
| Net Asset | 3.55 M |
About OWC Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OWC Pharmaceutical Research's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OWC Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OWC Pharmaceutical Research based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards OWC Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, OWC Pharmaceutical's short interest history, or implied volatility extrapolated from OWC Pharmaceutical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OWC Pharmaceutical Research. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the OWC Pharmaceutical information on this page should be used as a complementary analysis to other OWC Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for OWC Pink Sheet analysis
When running OWC Pharmaceutical's price analysis, check to measure OWC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OWC Pharmaceutical is operating at the current time. Most of OWC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of OWC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OWC Pharmaceutical's price. Additionally, you may evaluate how the addition of OWC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |